According to the DataM Intelligence: The global ophthalmology drugs market reached US$ 42.30 Billion with a rise of US$ 44.58 Billion in 2024 and is expected to reach US$ 73.97 Billion by 2033, growing at a CAGR of 5.83% during the forecast period 2025-2033.
Rising eye disorders are driving ophthalmology treatment demand. In 2023, FDA data reported 2.2 billion people with vision impairment, 1 billion preventable or untreated, while conditions like cataracts, refractive errors, diabetic retinopathy, glaucoma, and AMD cause a US$ 411 billion annual productivity loss globally.
Analyst Concludes: The #SeeWhatMatters campaign highlights the urgent need to preserve NEI’s independence and funding, that continued federal support is critical to sustaining U.S. leadership in vision research, enabling groundbreaking therapies, lowering long-term healthcare costs, and ensuring millions of Americans benefit from advanced treatments that protect and restore sight.
